Tobi Coker is a Deal Partner on the Investment team at Felicis. He works with the investment team to source and evaluate investments, conduct diligence, and work with existing portfolio companies. Previously, Tobi was an investor at The Production Board (TPB), a Bay Area-based early-stage venture firm, where he helped found and seed six companies in life sciences and human health. Before TPB, Tobi started his career in the Investment Banking and Capital Markets division at Morgan Stanley, providing coverage to healthcare and biotechnology companies. Currently, he is a Kauffman Fellow, class of 28, and an active member of BLCK VC. Tobi received a B.S. degree in Biology, with a minor in Economics from Georgetown University. Topics: 1. Key trends shaping the future of enterprise software investments 2. Role of AI in enhancing developer tools 3. Impact of open source on developer productivity #DeveloperTools #OpenSource #AIPowered #SoftwareDevelopment #TechInnovation

Dr. Charles Roberts is the Chief Investment Strategist of ARK Investment Management LLC (ARK Invest). As Chief Investment Strategist, Charles is responsible for providing inputs into research and strategies on both public and private markets, with a particular focus on AI and multiomics. In addition, Charles plays a key role in the strategy and execution of ARK’s venture capital efforts. Charles joined ARK in 2023. Prior to ARK, Charles's background is as a deep tech entrepreneur and serial founder with a focus on AI for social benefit, primarily in healthcare. He has been a cofounding executive at a number of companies including Freenome, a Bay Area based company of ~500 people working on saving lives through earlier cancer detection. Freenome currently is completing one of the world's largest ever clinical registrational studies in ~42,000 subjects, having raised $1.35B from leading investors including Roche, Novartis, Fidelity, Janus Henderson, and VCs including a16z, GV and DCVC. Charles also cofounded other AI/tech-bio companies including (as Chairperson) Relation Therapeutics Inc., also backed by DCVC, co-led with NVIDIA, plus Deerfield and other leading investors, with whom Relation completed $60M Seed in 2024. He cofounded biotech companies Agalimmune (acquired by a Nasdaq-listed biotech) and Centauri Tx, backed by Novo and Boerhinger Ingelheim, cofounded with the Nobel Laureate inventor of PCR. Charles also cofounded a non-invasive prenatal testing company that brought the first CE-marked NIPT test using next-generation sequencing to market. He has served as advisor to OSE, Oxford University’s ~$1B spin-out fund, and run a venture studio family office. Topics: - Investment in Disruptive Technologies - Future of AI and Multiomics - Role of AI in Investment Decisions #ARKInvest #VentureCapital #DisruptiveInnovation #AI #Biotech

Ryan Floyd is a founding Managing Director of Storm Ventures. He focuses on early stage enterprise SaaS and has primarily invested in applications and cloud/infrastructure related companies. Ryan is active and works with Code2040, a nonprofit organization that creates pathways to educational, professional, and entrepreneurial success in technology for underrepresented minorities. Topics: - Key Metrics for Evaluating SaaS Startups - Cloud Infrastructure and SaaS Investment Trends - The Impact of AI on Application Development #VentureCapital #SaaS #CloudInfrastructure #TechInnovation #AI

Quaid Walker is the Co-Founder and CEO at Bezel, a 100% authenticated, tech-first marketplace for buying and selling luxury watches. Backed by BoxGroup, Courtside Ventures, Shrug Capital, Abstract Ventures, Operator Partners, Kevin Hart, John Legend, J Balvin, Michael Rubin, Kyle Kuzma, Michael Ovitz, Steve Aoki, and execs + investors from Google, Snapchat, Accel, A16Z, Index, Gradient, QED, and more. Previously, he was a design lead at Google and a founding member of the Google TV team. Topics: - The future of luxury e-commerce - Building a powerful investor network - Scaling a successful marketplace #StartupLife #TechInnovation #VentureCapital #Entrepreneurship

Ullas Naik is the Founder and General Partner at Streamlined Ventures. At Streamlined, Ullas has led seed investments in almost 20 companies valued at over $1Bn, including iconic companies such as Doordash (IPO), Applovin (IPO), Rappi, Forge (IPO), EasyPost, OpenGov (acquisition), FLYR Labs, Rescale, Flip, Speechify, Medable, Bolt, and TubiTV (acquisition). Over the last 25 years, Ullas has seed/angel invested in nearly 150 companies. He is also an investor in numerous venture capital funds. Additionally, Ullas helped co-found the full lifecycle investment firm, Cota Capital. Prior to his current role, Ullas was a senior member of the investment team and helped build venture capital firm Globespan Capital Partners. At Globespan, they invested in early stage rounds of numerous iconic companies including Palo Alto Networks (IPO), Roku (IPO), Redfin (IPO), UpWork (IPO), BladeLogic (IPO), Virident (acquisition), Q1 Labs (acquisition), and Virtusa (IPO). Topics: - Evolution of Seed Stage Investing - AI and Data Science Trends - Building a Successful VC Fund #VentureCapital #Investing #StartupFunding #FundManagement #Entrepreneurship

Adam Coccari is the Managing Director of Intuit Ventures, Intuit’s Venture Capital team responsible for overseeing Intuit’s investment in startups around the world. Prior to Intuit, Adam spent 8 years at Microsoft where he was most recently a Partner at M12 – Microsoft’s Venture Fund. Topics: - The future of AI in financial services - Trends in B2B SaaS and SMB-focused technologies - AI-driven innovation strategy #VentureCapital #FinTech #AI #IntuitAssist #StartupInvesting #Innovation #SaaS

Rob Schutz is the co-founder of Ro, the DTC health company that was last valued at $7B, and employee #7 + former VP of Growth at Bark (box), where he helped grow the company from $0 to $100M in run rate. Now he is the founder of Snagged, where he helps entrepreneurs, startups, and established businesses acquire premium domain names. Topics: - Building billion-dollar companies: Insights from Ro and Bark - The role of growth strategies in scaling startups rapidly - The evolution of the domain name market and its impact on startups #StartupSuccess #DomainStrategy #BillionDollarFounder #GrowthHacking #DTCRevolution

Adam Besvinick is the Founder and Managing Partner at Looking Glass Capital, a pre-seed venture firm. Previously, he invested in Series A and later companies at Anchorage Capital Group, and before that, he was a pre-seed and seed investor at Deep Fork Capital. Prior to joining Deep Fork, Besvinick was the first business hire at Wanelo, leading partnership and monetization efforts. Before starting at Wanelo, he graduated from Harvard Business School, during which he worked part-time for Lowercase Capital, Gumroad, and a couple other early stage companies. He also used to co-lead By/Association, an angel investor group, which made three investments, including Transfix.io. Prior to entering business school, Besvinick was a telecom investment banker at Jefferies and graduated cum laude from Duke University in 2009. Topics: - Innovations in climate tech - The digital health revolution - Building a successful venture capital firm #ClimateInvesting #HealthTech #EmpowermentVC #ImpactVC #GreenTech

Keith is a Partner at Pear. Previously, Keith was an early-stage investor at Bessemer Venture Partners and a consultant at BCG, where he advised B2B, consumer, and energy companies on growth, strategy, and M&A. At Pear, Keith focuses on B2B applications including vertical software, enterprise software, and marketplaces. Additionally, he leads Pear’s roadmap on emerging XR/AR/VR and spatial computing platforms. Keith is originally from Arizona and is based in Palo Alto. He holds a BA in English from Harvard College and an MBA from Harvard Business School. Topics: 1. Analytics-Driven Investing in the Tech World 2. Navigating the Next Wave of Enterprise Tech Innovation 3. The Secret to Startup Succes #VentureCapital #B2BSoftware #StartupInvestor #ARVRInnovation #EnterpriseTech

Daniel Faierman is a partner at Habitat Partners, an early stage venture capital firm based in New York that focuses on Pre-Seed to Series A investments in consumer and software companies. After playing division one tennis at Yale, Daniel gained deep operating experience at multinational consumer brand enterprises such as PepsiCo and AB InBev across finance, brand strategy, and innovation. With a major passion for health and wellness, Daniel's VC journey commenced at Selva Ventures. He later attended the Stanford GSB, where he launched his own investing entity, Vitality Ventures, building it to over 400 LPs and still actively deploying today. Prior to joining Habitat Partners, Daniel led finance at GSB-founded startup Forum Brands. Daniel splits most of his time at Habitat between CPG and B2B SaaS with a focus on commerce enablement and marketing/advertising technology. Topics: - Insights on pre-seed to Series A investing strategies in the current market - Balancing CPG and B2B SaaS investments in early-stage ventures - Lessons in scaling a venture capital fund's investor network #VentureCapital #StartupInvesting #EarlyStage #ConsumerTech #SaaS